Medicare Premiums Increase in 2026
The Centers for Medicare & Medicaid Services (CMS) has just rolled out the latest adjustments for Medicare Parts A and B, effective January 1, 2026. If you’re enrolled in Medicare
The Latest on Canada-US Tariffs
The U.S. suspension of the duty-free “de minimis” threshold for low-value shipments, which took effect on August 29, 2025, continues to reshape cross-border shopping from Canada.
Exercise Skin Revival Strategies
Your skin is more than just a protective barrier—it’s a silent communicator, whispering (or sometimes shouting) about its needs, especially during and after physical activity.
Trump Policies Push Doctors to Canada
A prominent Ottawa heart surgeon, Dr. Marc Ruel, had planned to join the University of California, San Francisco, to lead their heart surgery division.
New U.S. Duty Rules
What Shoppers Need to Know Starting August 29, 2025, shopping from Canadian businesses and shipping to the U.S. will come with some changes due to new U.S. customs regulations. The
Health Systems Brace for Medicaid Cuts
Hospitals, health systems, and physician practices are recalibrating their operational and financial strategies to navigate evolving federal regulations, according to a recent KLAS Research survey.
Helping Patients Navigate Medicaid Cuts
Recent federal budget cuts signed into law by President Donald Trump are set to impact healthcare access significantly. Over the next decade, the Congressional Budget Office projects that approximately 12
US Employers Shift Benefits Costs
A 2025 Mercer survey of over 500 large U.S. employers (500+ employees) indicates significant changes in employee benefits for 2026, with a focus on cost management and innovative healthcare solutions.
Novo Nordisk’s Patent Lapse Opens Door For Generics
Hims & Hers Health, a U.S.-based telehealth platform, plans to enter the Canadian market in 2026, offering generic semaglutide drugs following the expiration of Novo
Medicaid Cut Care Solutions
On July 4, 2025, President Donald Trump signed the One Big Beautiful Bill Act (OBBBA) into law, enacting sweeping changes to the U.S. healthcare system. The legislation, passed by a
Biosimilars for Psoriasis Unlocking Affordable Treatment
For the over 8 million Americans living with psoriasis, biosimilars offer a promising path to more affordable treatment. These medications, designed to closely mimic costly biologics like Humira, Enbrel, Remicade,
AI Tool Enhances Personalized Cancer Care
A groundbreaking AI tool, AAnet, developed by a multinational research team led by the Garvan Institute of Medical Research and Yale University, is poised to transform cancer treatment.
Twice-Yearly HIV Shot Gets FDA Greenlight
The U.S. Food and Drug Administration has approved a groundbreaking twice-yearly injection called Yeztugo (lenacapavir) for HIV prevention, developed by Gilead Sciences.
Medicaid Reforms Pass House in Budget Bill
On May 22, 2025, the House of Representatives passed H.R. 119, the “One Big Beautiful Bill Act,” in a razor-thin 215-214 vote, with only Republican support. Championed by President Donald
Major Trial to Test Drugs Like Ozempic for Cancer Prevention
A groundbreaking initiative in the UK aims to offer weight-loss injections, such as Ozempic, Wegovy, and Mounjaro, to tens of thousands of patients as a preventive measure against cancer. This